- 2023 Multidisciplinary Oncology Review
- 2022
- Videos
- 2021
- 2020
- 2019
- Hematology & Medical Oncology Review 2019
- 2018
- Events
Playback speed
10 seconds
ASH Update on MDS Management: What Are the Outcomes of Venetoclax for Higher Risk MDS? Can We Expect to See Venetoclax + AZA as a New SoC?
166 views
March 5, 2021
Comments 0
Login to view comments.
Click here to Login
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases